🔴 BioLineRx is trading 5% down with no company-specific catalyst identified

BioLineRx is trading at $2.02 (-5.16%), with no specific cause established for the decline.

• No new company-specific announcement was identified for October 21; BioLineRx’s investor-relations page lists its latest release as October 8.
• The decline follows an 11.84% gain in the prior session. XBI was reported roughly steady in pre-market trading after a strong prior session, offering no clear sector explanation.
• No reliable live volume or activity detail was available.